SavedAdd your journal

Journals / Türk Nöroloji Dergisi / 2018 / Cilt: 24 - Sayı: 4

Clinical and Prognostic Evaluation of Myelin Oligodendrocyte Glycoprotein Autoimmunity in the Central Nervous System

Merkezi Sinir Sisteminde Miyelin Oligodendrosit Glikoprotein Otoimmünitesinin Klinik ve Prognostik Açıdan Değerlendirilmesi

Murat KÜRTÜNCÜ
Volkan TAŞDEMİR
Pages
350–351
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KÜRTÜNCÜ, M., TAŞDEMİR, V. (2022). Clinical and Prognostic Evaluation of Myelin Oligodendrocyte Glycoprotein Autoimmunity in the Central Nervous System. Türk Nöroloji Dergisi, Cilt: 24 - Sayı: 4, 350–351. https://ajindex.com/articles/636801

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Jarius S, Wildemann B. Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature. Brain Pathol 2013;23:661-683.
  2. Johns TG, Bernard CC. The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem 1999;72:1-9.
  3. Cobo-Calvo A, Ruiz A, Maillart E, at al; OFSEP and NOMADMUS Study Group. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology 2018;90:e1858-e1869. Kaneko K, Sato DK, Nakashima I, et al. Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies. J Neurol Neurosurg Psychiatry 2016;87:1257-1259.